It is noteworthy that HCT116 is a highly aggressive cell line with a reduced capacity to differentiate compared to HT29 cells [62], and, unlike HT29, it carries a KRAS mutation, which is a frequent and early event in CRC tumorigenesis [63]. The gene discussed is KRAS; the disease is colorectal carcinoma.